Antabuse (Disulfiram) 250 mg / 500 mg Tablets: Prescription Aldehyde Dehydrogenase Inhibitor Aversion Therapy for Alcohol Use Disorder

Reviewed by the Lucas Clinic Medical Team | Updated May 2026

Disulfiram (Antabuse) is a unique pharmacological approach to alcohol use disorder: rather than reducing craving, altering neurotransmitter systems, or blocking reward, it works as an aversion agent — making alcohol consumption acutely and severely unpleasant (and potentially life-threatening) through inhibition of the enzyme aldehyde dehydrogenase (ALDH). When a person taking disulfiram consumes any alcohol, acetaldehyde (the first oxidative metabolite of ethanol) accumulates to toxic concentrations — normally acetaldehyde is rapidly converted to acetate by ALDH, but disulfiram blocks this step. The resulting acetaldehyde excess causes the disulfiram-ethanol reaction (DER).

The DER is characterised by: intense facial flushing and sweating, throbbing headache, nausea and profuse vomiting, palpitations, tachycardia, hypotension, dyspnoea, blurred vision, and intense anxiety. Severe DER reactions — particularly with large alcohol ingestion — can progress to life-threatening hypotension, arrhythmias, seizures, myocardial infarction, and death. Even small amounts of alcohol (wine vinegar in salad dressing, mouthwash containing ethanol, alcohol-based topical preparations) can trigger DER in sensitive individuals. For disulfiram to function as intended — as a pharmacological deterrent — the patient must understand and accept this risk before starting treatment. Prescribing disulfiram to an un-consenting or uninformed patient is ethically impermissible.

What Is Antabuse (Disulfiram)?

Disulfiram was serendipitously discovered in 1948 when rubber industry workers exposed to tetraethylthiuram disulfide became ill after drinking alcohol. Clinical research rapidly translated this observation into pharmacotherapy. Disulfiram inhibits both ALDH1 (cytosolic aldehyde dehydrogenase) and ALDH2 (mitochondrial), preventing the conversion of acetaldehyde to acetate. The drug has a slow onset and prolonged duration — disulfiram's inhibitory effects on ALDH persist for up to 1–2 weeks after the last dose (due to irreversible enzyme inhibition requiring new enzyme synthesis to restore ALDH activity). A patient who stops taking disulfiram remains at risk of DER for 1–2 weeks and must be counselled accordingly.

Disulfiram is most effective when its use is supervised — family members, recovery coaches, or healthcare workers confirming daily ingestion significantly improves adherence and outcome. Unsupervised use has lower adherence and therefore lower clinical effectiveness. Disulfiram is not suitable for patients who cannot commit to complete alcohol abstinence, who have severe cardiac disease (the DER could be fatal), active psychosis, or hypothyroidism. Liver function should be monitored — disulfiram can cause hepatotoxicity (rare but potentially severe). Disulfiram inhibits cytochrome P450 2E1 and has significant drug interactions: it potentiates the effects of warfarin, phenytoin, and isoniazid, and its concurrent use with metronidazole (Flagyl) or tinidazole is contraindicated due to risk of psychotic reactions.

Prescription vs. Over-the-Counter Status

Disulfiram (Antabuse and generic) is a prescription-only medication. The inherent risks of the DER, the requirement for pre-treatment assessment including cardiac evaluation, the necessity of ALDH reaction education, and the drug interaction profile all necessitate physician prescribing. Informed consent documentation before initiation is considered best practice. Disulfiram is not appropriate for self-initiation or over-the-counter availability. Treatment should be part of a comprehensive addiction medicine programme with regular medical follow-up including liver function monitoring.

Available Strengths and Forms

Disulfiram is available in two strengths: 250 mg and 500 mg tablets. The standard initial dose is 500 mg once daily for the first 1–2 weeks (some clinicians prefer a lower starting dose of 250 mg to assess tolerability). Maintenance dose is typically 250 mg once daily (range 125–500 mg/day). Tablets are taken orally once daily, at the same time each day — often advised in the morning to allow declining plasma level through the night (though once-daily dosing provides consistent ALDH inhibition throughout the day). Generic disulfiram 250 mg tablets are the most commonly prescribed form. No injectable formulation is commercially available in the US (unlike some European markets where subcutaneous implants have been used in specialist settings). The drug must be stored out of reach of others who might be harmed by inadvertent access.

Price of Antabuse / Disulfiram

Generic disulfiram is inexpensive — 30 tablets of 250 mg cost approximately $15–$40 at most US pharmacies with discount programmes. Branded Antabuse is rarely prescribed due to cost relative to generics. With insurance coverage, disulfiram is typically covered in the generic form. The low acquisition cost of disulfiram makes it a maximally cost-effective pharmacotherapy option for AUD compared to the economic burden of untreated alcohol use disorder. Patient assistance programmes are available for individuals without insurance coverage through various state SAMHSA programmes.

Frequently Asked Questions

What common products contain hidden alcohol that can trigger DER?

Patients on disulfiram are often surprised by the breadth of products that can trigger DER. Alcohol-containing mouthwashes (Listerine Original contains 26.9% ethanol) are a frequently overlooked trigger. Over-the-counter cough syrups and liquid cold medications often contain ethanol. Cooking with wine or other spirits — even with evaporation — can leave residual alcohol. Vinegar (wine vinegar, cider vinegar) contains ethanol. Alcohol-based topical products: aftershave, perfumes, certain skin antiseptics, hand sanitisers (though systemic absorption from brief topical use is typically insufficient to trigger DER in most patients). Fermented foods (kombucha), non-alcoholic beers (which contain residual ethanol of 0.3–0.5%), and some ice creams or desserts with alcohol flavourings. Patients should read all ingredient labels and explicitly ask pharmacists to check all new medications for alcohol content before dispensing.

How long does disulfiram stay active after the last dose?

Disulfiram's effects on ALDH persist for approximately 1–2 weeks after the last dose. This is because disulfiram (and its active metabolite diethyldithiocarbamate) forms covalent bonds with ALDH — irreversibly inhibiting the enzyme. Restoration of ALDH activity requires synthesis of new enzyme, which takes approximately 1–2 weeks. Practically, this means: a patient who misses a day or two of disulfiram still has significant ALDH inhibition and remains at risk of DER. It also means that if a patient decides to stop taking disulfiram and drink alcohol, they must wait at least 1–2 weeks after their last tablet before alcohol can be consumed safely. This period of residual protection can be clinically useful but must be clearly explained so patients do not mistakenly believe that missing a dose allows immediate "safe" drinking.

Who should not take disulfiram?

Disulfiram is contraindicated in patients who have recently consumed alcohol (within 12 hours of first dose — baseline sobriety required). Serious contraindications include: severe myocardial disease or coronary artery disease (DER cardiovascular effects could be fatal); active psychosis or psychotic disorder (disulfiram can exacerbate psychosis); severe hepatic impairment (hepatotoxicity risk) — baseline LFTs required and monitoring during treatment; hypersensitivity to disulfiram or thiuram derivatives; concurrent metronidazole or tinidazole use (risk of acute psychotic episode); rubber industry workers with occupational thiuram exposure. Relative contraindications include diabetes mellitus (DER-related hypotension may unmask or exacerbate cardiovascular complications), hypothyroidism, and seizure disorder. The prescribing physician must perform a thorough pre-treatment medical assessment before initiating disulfiram.

← Back to Dependence Medications